Literature DB >> 19570862

Origin of expression of the herpes simplex virus type 1 protein U(S)1.5.

J Jason Bowman1, Priscilla A Schaffer.   

Abstract

ICP22, an immediate-early protein of herpes simplex virus type 1 (HSV-1), is required for viral replication in nonpermissive cell types and for expression of a class of late viral proteins which includes glycoprotein C. An understanding of the mechanism of ICP22 function has been complicated by the coexpression of the full-length protein with an in-frame, C-terminus-specific protein, U(S)1.5. In this report, we confirm that the U(S)1.5 protein is a bona fide translation product since it is detected during infections with three laboratory strains and two low-passage clinical isolates of HSV-1. To clarify the expression patterns of the ICP22 and U(S)1.5 proteins, we examined their synthesis from plasmids in transient expression assays. Because previous studies had identified two different U(S)1.5 translational start sites, we attempted to determine which is correct by studying the effects of a series of deletion, nonsense, and methionine substitutions on U(S)1.5 expression. First, amino acids 90 to 420 encoded by the ICP22 open reading frame (ORF) migrated at the mobility of U(S)1.5 in sodium dodecyl sulfate-polyacrylamide gels. Second, introduction of a stop codon downstream of M90 ablated expression of both ICP22 and U(S)1.5. Finally, mutation of M90 to alanine (M90A) allowed expression of full-length ICP22 while dramatically reducing expression of U(S)1.5. Levels of U(S)1.5 but not ICP22 protein expression were also reduced in cells infected with an M90A mutant virus. Thus, we conclude that expression of IC22 and that of U(S)1.5 can occur independently of each other and that U(S)1.5 translation initiates at M90 of the ICP22 ORF.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19570862      PMCID: PMC2738232          DOI: 10.1128/JVI.00984-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  28 in total

1.  Infected cell protein No. 22 is subject to proteolytic cleavage by caspases activated by a mutant that induces apoptosis.

Authors:  Joshua Munger; Ryan Hagglund; Bernard Roizman
Journal:  Virology       Date:  2003-01-20       Impact factor: 3.616

Review 2.  Structural features in eukaryotic mRNAs that modulate the initiation of translation.

Authors:  M Kozak
Journal:  J Biol Chem       Date:  1991-10-25       Impact factor: 5.157

3.  Transient expression of herpes simplex virus type 1 ICP22 represses viral promoter activity and complements the replication of an ICP22 null virus.

Authors:  J Jason Bowman; Joseph S Orlando; David J Davido; Anna S Kushnir; Priscilla A Schaffer
Journal:  J Virol       Date:  2009-06-17       Impact factor: 5.103

4.  In vitro characterization of a herpes simplex virus type 1 ICP22 deletion mutant.

Authors:  K L Poffenberger; P E Raichlen; R C Herman
Journal:  Virus Genes       Date:  1993-06       Impact factor: 2.332

5.  Processing of the herpes simplex virus regulatory protein alpha 22 mediated by the UL13 protein kinase determines the accumulation of a subset of alpha and gamma mRNAs and proteins in infected cells.

Authors:  F C Purves; W O Ogle; B Roizman
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

6.  A generalized technique for deletion of specific genes in large genomes: alpha gene 22 of herpes simplex virus 1 is not essential for growth.

Authors:  L E Post; B Roizman
Journal:  Cell       Date:  1981-07       Impact factor: 41.582

7.  Posttranslational processing of infected cell protein 22 mediated by viral protein kinases is sensitive to amino acid substitutions at distant sites and can be cell-type specific.

Authors:  A P Poon; W O Ogle; B Roizman
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

8.  Tyrosine 116 of the herpes simplex virus type 1 IEalpha22 protein is an ocular virulence determinant and potential phosphorylation site.

Authors:  Curtis R Brandt; Aaron W Kolb
Journal:  Invest Ophthalmol Vis Sci       Date:  2003-11       Impact factor: 4.799

9.  Herpes simplex virus 1 mutant deleted in the alpha 22 gene: growth and gene expression in permissive and restrictive cells and establishment of latency in mice.

Authors:  A E Sears; I W Halliburton; B Meignier; S Silver; B Roizman
Journal:  J Virol       Date:  1985-08       Impact factor: 5.103

10.  Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate-early regulatory protein ICP4.

Authors:  N A DeLuca; A M McCarthy; P A Schaffer
Journal:  J Virol       Date:  1985-11       Impact factor: 5.103

View more
  7 in total

1.  Sequence variation in the herpes simplex virus U(S)1 ocular virulence determinant.

Authors:  Aaron W Kolb; Timothy R Schmidt; David W Dyer; Curtis R Brandt
Journal:  Invest Ophthalmol Vis Sci       Date:  2011-06-28       Impact factor: 4.799

2.  Varicella-Zoster Virus ORF63 Protects Human Neuronal and Keratinocyte Cell Lines from Apoptosis and Changes Its Localization upon Apoptosis Induction.

Authors:  Chelsea Gerada; Megan Steain; Brian P McSharry; Barry Slobedman; Allison Abendroth
Journal:  J Virol       Date:  2018-05-29       Impact factor: 5.103

3.  Herpes simplex virus 1 ICP22 but not US 1.5 is required for efficient acute replication in mice and VICE domain formation.

Authors:  Heba H Mostafa; David J Davido
Journal:  J Virol       Date:  2013-10-02       Impact factor: 5.103

4.  Comprehensive characterization of interaction complexes of herpes simplex virus type 1 ICP22, UL3, UL4, and UL20.5.

Authors:  Junji Xing; Shuai Wang; Fusen Lin; Weiwei Pan; Chang-Deng Hu; Chunfu Zheng
Journal:  J Virol       Date:  2010-12-08       Impact factor: 6.549

5.  Herpes Simplex Virus 1 (HSV-1) ICP22 protein directly interacts with cyclin-dependent kinase (CDK)9 to inhibit RNA polymerase II transcription elongation.

Authors:  Justyna Zaborowska; Sonja Baumli; Clelia Laitem; Dawn O'Reilly; Peter H Thomas; Peter O'Hare; Shona Murphy
Journal:  PLoS One       Date:  2014-09-18       Impact factor: 3.240

Review 6.  The suppression of apoptosis by α-herpesvirus.

Authors:  Yu You; An-Chun Cheng; Ming-Shu Wang; Ren-Yong Jia; Kun-Feng Sun; Qiao Yang; Ying Wu; Dekang Zhu; Shun Chen; Ma-Feng Liu; Xin-Xin Zhao; Xiao-Yue Chen
Journal:  Cell Death Dis       Date:  2017-04-13       Impact factor: 8.469

Review 7.  ICP22/IE63 Mediated Transcriptional Regulation and Immune Evasion: Two Important Survival Strategies for Alphaherpesviruses.

Authors:  Qing He; Ying Wu; Mingshu Wang; Shun Chen; Renyong Jia; Qiao Yang; Dekang Zhu; Mafeng Liu; Xinxin Zhao; Shaqiu Zhang; Juan Huang; Xumin Ou; Sai Mao; Qun Gao; Di Sun; Bin Tian; Anchun Cheng
Journal:  Front Immunol       Date:  2021-12-02       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.